| 1554 |
National Cancer Institute |
Html |
en |
Chronic Lymphocytic Leukemia Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of chronic lymphocytic leukemia. |
| red blood cells | 0.517668 |
| cancer treatment | 0.431205 |
| malignant tumor cells | 0.395015 |
| blood -forming cells | 0.386238 |
| body | 0.377277 |
| PDQ cancer information | 0.428983 |
| clinical trial search | 0.381057 |
| white blood cells | 0.437124 |
| clinical trials | 0.679889 |
| mature blood cells | 0.419721 |
| Natural killer cells | 0.383894 |
| cancer information summary | 0.40184 |
| clinical trial | 0.489229 |
| lymphocytes | 0.390185 |
| Lymphoblastic Leukemia Treatment | 0.406769 |
| Myeloid Leukemia Treatment | 0.391192 |
| blood cells | 0.552101 |
| immature cells | 0.367988 |
| treatment clinical trial | 0.370422 |
| IgVH gene mutation | 0.385864 |
| Cell Leukemia Treatment | 0.388308 |
| NCI PDQ cancer | 0.372246 |
| lymph nodes | 0.416068 |
| Treatment Editorial Board | 0.376334 |
|
| radiation therapy | 0.372299 |
| tyrosine kinase inhibitor | 0.394203 |
| treatment | 0.577005 |
| stored stem cells | 0.374171 |
| myeloid stem cell | 0.372796 |
| immature blood cells | 0.385722 |
| cancer cells | 0.498635 |
| lymphoid stem cell | 0.371902 |
| specific cancer cells | 0.395788 |
| Lymphocytic Leukemia Treatment | 0.392931 |
| treatment clinical trials | 0.392666 |
| Acute Lymphoblastic Leukemia | 0.387556 |
| blood stem cells | 0.421035 |
| National Cancer Institute | 0.439036 |
| normal cells | 0.375452 |
| new treatment | 0.432006 |
| bone marrow | 0.466319 |
| chronic lymphocytic leukemia | 0.905376 |
| cells | 0.56649 |
| cancer clinical trials | 0.397834 |
| cancer | 0.596361 |
| Myelogenous Leukemia Treatment | 0.383031 |
| standard treatment | 0.368392 |
| Leukemia Treatment | 0.421626 |
|
CLICK HERE |
| 1623 |
National Cancer Institute |
Html |
null |
Gonzalez Regimen (PDQ®)–Health Professional Version |
The Gonzalez regimen is a specialized diet that uses enzymes, supplements, and other factors in cancer management based on a theory that involves the use of pancreatic enzymes to help the body get rid of toxins that lead to cancer. Read about existing clinical data in this expert-reviewed summary. |
|
|
CLICK HERE |
| 1777 |
National Cancer Institute |
Html |
es |
El dolor y el cáncer (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del dolor como una complicación a causa del cáncer o su tratamiento. Se tratan abordajes para el control y el tratamiento del dolor relacionado con el cáncer. |
| Moderate Cancer Pain | 0.337641 |
| among patients with | 0.313833 |
| Curr Pain Headache | 0.353041 |
| Palliat Nurs | 0.30942 |
| Chronic Pain Syndromes | 0.356907 |
| Breakthrough Pain Study | 0.329475 |
| Pain Questionnaire | 0.327384 |
| Jensen MP | 0.310829 |
| Cancer Therapy | 0.30947 |
| with breast cancer | 0.313155 |
| Edmonton Symptom Assessment | 0.309493 |
| Pain Terms | 0.351866 |
| pain management | 0.434176 |
| Natl Cancer Inst | 0.310759 |
| Hui D | 0.310443 |
| pain syndromes | 0.398674 |
| Faces Pain Scale | 0.329845 |
| Pain Res | 0.344114 |
| patients with | 0.479951 |
| Pain Symptom Manage | 0.524062 |
| Pain Experience among | 0.326556 |
| Pain Management Nursing | 0.328639 |
| chronic pain | 0.526592 |
| dolor).¿El dolor | 0.346176 |
| Oncol Nurs Forum | 0.309327 |
|
| peor dolor | 0.357775 |
| pain assessment | 0.342098 |
| Care Cancer | 0.331083 |
| breakthrough pain | 0.366572 |
| palliative care | 0.309739 |
| Hosp Palliat Care | 0.329839 |
| Faces Pain | 0.365306 |
| Pain related | 0.328906 |
| pain assessment toolkit | 0.327388 |
| pain control | 0.351552 |
| patients with depression | 0.30909 |
| Brief Pain Inventory | 0.377512 |
| Pain Headache Rep | 0.352431 |
| cancer pain | 0.974628 |
| cancer pain prognostic | 0.363979 |
| pain experience | 0.342944 |
| Clin Oncol | 0.363176 |
| Palliat Med | 0.324432 |
| pain's interference with | 0.332203 |
| breast cancer | 0.321556 |
| Bruera E | 0.316817 |
| edmonton staging system | 0.310908 |
| systematic review | 0.31986 |
| Faces Pain Scale-Revised | 0.327413 |
|
CLICK HERE |
| 1858 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de glándulas salivales (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de glándulas salivales. |
| salivary gland carcinoma | 0.756611 |
| salivary neoplasms | 0.424559 |
| estroma linfoide | 0.413137 |
| prognostic factors | 0.41902 |
| gland tumours | 0.43032 |
| Spiro RH | 0.465562 |
| Sin embargo | 0.429856 |
| advanced salivary | 0.421758 |
| Malignant parotid tumors | 0.41189 |
| minor salivary | 0.423431 |
| tumores benignos | 0.597781 |
| Salivary Gland Disease | 0.423228 |
| tumores malignos mixtos | 0.484605 |
| botulinum toxin | 0.428989 |
| Radiat Oncol Biol | 0.471433 |
| glándulas salivales benignos | 0.570833 |
| neck neoplasia following | 0.437258 |
| fuerte predilección | 0.414088 |
| Parotid gland tumours | 0.420714 |
| salivary gland | 0.859636 |
| Head Neck Surg | 0.476609 |
| mucoepidermoid carcinoma | 0.597885 |
| gland malignant neoplasms | 0.445484 |
| tumores benignos mixtos | 0.438326 |
| único sÃntoma | 0.425265 |
|
| parotid gland | 0.431427 |
| lesiones carcinoma | 0.466113 |
| relativa frecuencia | 0.450675 |
| sección carcinoma | 0.486375 |
| carcinoma ex-tumor | 0.470245 |
| unresectable carcinomas | 0.426636 |
| Oral Oncol | 0.420027 |
| major salivary glands | 0.414421 |
| Otolaryngol Head Neck | 0.413034 |
| término carcinoma | 0.475993 |
| carcinoma epidermoide | 0.472012 |
| edad promedio | 0.670934 |
| Salivary Gland Tumours | 0.424182 |
| carcinoma with | 0.481329 |
| adenocarcinoma sai | 0.463524 |
| carcinoma salival basaloide | 0.481935 |
| carcinomas quÃsticos adenoides | 0.459095 |
| Botulinum toxin treatment | 0.413697 |
| with parotid carcinoma | 0.483397 |
| Oncol Biol Phys | 0.47266 |
| linfadenoma sebáceo | 0.417003 |
| elemento carcinoma | 0.475416 |
| carcinoma mucoepidermoide | 0.988653 |
| neoplasias benignas | 0.45166 |
|
CLICK HERE |
| 1933 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de seno (mama) en el embarazo (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de cáncer de seno (mama) en el embarazo. |
| estadio lllC | 0.545921 |
| procedimientos quizás | 0.519027 |
| estadio iv | 0.622294 |
| siguientes aspectos | 0.528664 |
| secciones llamadas lóbulos | 0.542754 |
| estadio lllB | 0.547235 |
| estadio lllA | 0.548629 |
| estadios ia | 0.51696 |
| ganglio linfático centinela | 0.983407 |
| Oncotype DX | 0.522717 |
| rayos x | 0.518956 |
| estadio ib | 0.594193 |
| prueba ayuda | 0.551927 |
| estadio ia | 0.593122 |
| pezón afección | 0.529911 |
| enlace drugs approved | 0.522117 |
| mama.ampliar cirugÃa | 0.515861 |
| causó hinchazón | 0.517244 |
| National Cancer Institute | 0.51629 |
| cuántos genes | 0.520169 |
|
| siguientes riesgos | 0.513473 |
| realidad células | 0.541214 |
| Instituto Nacional | 0.528985 |
| cuáles lesiones | 0.51826 |
| estadio iiia | 0.547361 |
| PDQ Tratamiento | 0.523188 |
| estadio iiic | 0.745067 |
| cáncer.ampliar mamografÃa | 0.525478 |
| estadio iia | 0.550898 |
| estadio llB | 0.548944 |
| estadio llA | 0.550289 |
| cuánta proteÃna | 0.522295 |
| siguientes casos | 0.520535 |
| Physician Data Query | 0.558856 |
| carcinoma lobulillar | 0.602006 |
| siguientes partes | 0.548502 |
| Breast Cancer | 0.511799 |
| mamas.ampliar carcinoma lobulillar | 0.536157 |
| siguientes pruebas | 0.564002 |
| vasos sanguÃneos | 0.630183 |
|
CLICK HERE |
| 1955 |
National Cancer Institute |
Html |
es |
Tratamiento de la micosis fungoide (incluso el síndrome de Sézary) (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de la micosis fungoide (incluso el síndrome de Sézary). |
| siguientes procedimientos | 0.303227 |
| células madre | 0.320527 |
| estadio iv | 0.313697 |
| La micosis fungoide | 0.416261 |
| llamada terapia | 0.301315 |
| Estadio IIA | 0.301756 |
| vÃa oral | 0.300639 |
| Estadio IIB | 0.301746 |
| rayos x | 0.300779 |
| estadio ivb | 0.303346 |
| estadio ib | 0.303433 |
| enlace drugs approved | 0.306299 |
| estadio ia | 0.303396 |
| radioterapia ultravioleta | 0.303448 |
| micosis fungoide | 0.995318 |
| célula madre mieloide | 0.305243 |
| células t | 0.307128 |
| madre sanguÃneas maduras | 0.302125 |
| luz solar | 0.300631 |
| estadio iva | 0.303278 |
|
| quimioterapia sistémica | 0.305438 |
| National Cancer Institute | 0.300622 |
| Instituto Nacional | 0.301086 |
| célula madre linfoide | 0.305924 |
| PDQ Tratamiento | 0.301318 |
| partÃculas minúsculas | 0.300672 |
| presente sección | 0.300525 |
| llamada fotoquimioterapia | 0.300664 |
| Physician Data Query | 0.302237 |
| Non-Hodgkin Lymphoma | 0.303589 |
| estadio iii | 0.306895 |
| lesiones cutáneas | 0.300795 |
| radiación ultravioleta a | 0.301198 |
| célula madre | 0.319745 |
| luz ultravioleta | 0.30088 |
| ósea elabora células | 0.304191 |
| radiación ultravioleta | 0.315951 |
| Sézary recidivantes | 0.302362 |
| siguientes sumarios | 0.301672 |
| siguientes pruebas | 0.301109 |
|
CLICK HERE |
| 3528 |
National Cancer Institute |
Html |
es |
Dosis altas de vitamina C (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer. |
| Natl Acad Sci | 0.417663 |
| ascorbic acid with | 0.319941 |
| Toxicol In Vitro | 0.313376 |
| Sin embargo | 0.355085 |
| exhibit antitumoral effects | 0.313224 |
| Pauling L | 0.325518 |
| Vitamin C | 0.326615 |
| vitamina c | 0.479277 |
| ascorbate enhanced chemosensitivity | 0.326919 |
| Instituto Nacional | 0.312833 |
| Cancer Res | 0.390148 |
| Chen Q | 0.342148 |
| patients with advanced | 0.354811 |
| supportive treatment | 0.331337 |
| Pharmacologic concentrations | 0.313247 |
| In vitro screening | 0.313326 |
| Med Oncol | 0.314224 |
| acid combination therapy | 0.340469 |
| with ascorbic acid | 0.337638 |
| Padayatty SJ | 0.360813 |
| Levine M | 0.40315 |
| patients with | 0.414812 |
| administración iv | 0.317377 |
| ascorbic acid | 0.947894 |
| estadio iv | 0.317436 |
|
| Pharmacologic doses | 0.312587 |
| voluntarios sanos | 0.317063 |
| intravenous ascorbic acid | 0.330687 |
| Proc Natl Acad | 0.418979 |
| benefit patients with | 0.32288 |
| Biol Blood Marrow | 0.314132 |
| acid therapy | 0.32123 |
| relapsed or refractory | 0.319928 |
| Nutr Cancer | 0.315186 |
| parenteral ascorbate enhanced | 0.327964 |
| National Cancer Institute | 0.323649 |
| ácido ascórbico iv | 0.317065 |
| Transl Med | 0.334599 |
| Intern Med | 0.343771 |
| Chemother Pharmacol | 0.319656 |
| Espey MG | 0.344722 |
| Sun AY | 0.318432 |
| Moertel CG | 0.319183 |
| Chem Biol Interact | 0.340687 |
| phase ii | 0.326203 |
| in vitro | 0.345448 |
| high-dose vitamin | 0.327502 |
| High-dose parenteral ascorbate | 0.330109 |
| ascorbic acid induces | 0.316289 |
|
CLICK HERE |
| 3889 |
National Cancer Institute |
Html |
en |
Parents Who Have a Child with Cancer |
Practical information for parents, when a child has cancer. Tips to help kids and parents cope and stay strong, together with answers to commonly asked questions from parents and children. |
| questions | 0.35493 |
| child life specialist | 0.386505 |
| child’s treatment | 0.35347 |
| child stay | 0.349619 |
| professional help | 0.33179 |
| health care team | 0.725323 |
| integrative medicine | 0.336877 |
| School-aged children | 0.334822 |
| illness children | 0.331523 |
| children | 0.600994 |
| social worker | 0.38279 |
| young children | 0.353967 |
| talk | 0.366273 |
| guide | 0.345294 |
| social media site | 0.334677 |
| individualized education plan | 0.336753 |
| Older children | 0.332601 |
| Child Fights | 0.345493 |
| child’s diagnosis | 0.353024 |
| child react | 0.353407 |
| physical changes | 0.337307 |
| friends | 0.368904 |
| child | 0.906189 |
| parents | 0.404038 |
| treatment | 0.408118 |
|
| Childhood Cancer section | 0.347255 |
| emotional changes | 0.3435 |
| mental health specialist | 0.336601 |
| Children’s Hospital | 0.33095 |
| Stay Strong section | 0.335513 |
| ways | 0.385896 |
| Integrative medicine practices | 0.335837 |
| hospital | 0.356973 |
| social media | 0.340134 |
| people | 0.356129 |
| primary care doctor | 0.338718 |
| way | 0.329858 |
| doctor | 0.358256 |
| child play | 0.355719 |
| school your child | 0.347225 |
| social media sites | 0.338017 |
| new medical information | 0.336758 |
| cancer | 0.500444 |
| information | 0.37152 |
| suggestions | 0.340134 |
| time | 0.433424 |
| family | 0.348424 |
| difficult time | 0.340015 |
| medical situation | 0.335063 |
|
CLICK HERE |
| 16256 |
National Cancer Institute |
Html |
en |
Áreas de investigación |
Sostener un progreso contra el cáncer requiere que se avance a través del continuo de investigación. Entérese de lo extenso que es el trabajo del NCI y de los programas que apoya el instituto para hacer avanzar la investigación oncológica. |
| National Cancer Institute | 0.966549 |
|
|
CLICK HERE |
| 17294 |
National Cancer Institute |
Html |
es |
Anemia |
Información y consejos para controlar la anemia, un efecto secundario del tratamiento del cáncer.
|
| suficientes glóbulos | 0.941582 |
|
|
CLICK HERE |